One thing that stuck with me in my head was that because women have lower mortality rates but higher morbidity rates, they are essentially leading lower quality lives. Although women live longer, more of their years are spent having to fight chronic or acute illness.

The question as to why extensive study has not been conducted also concerned me. While, of course, it would be beneficial to conduct studies to the biological difference in treatment reactions, disease occurrence, I would assume that the high costs of the studies may deter people. However, I would think that being able to effectively treat illnesses in women, as opposed to trying to use the same medicines as men, would be a good enough reason to invest in further studies. If for nothing else, you would think that pharmaceutical companies would want to market even more newly developed female-specific drugs as more effective as a result of such research studies.